Apple has started testing DRAM chips from China's state-backed ChangXin Memory Technologies (CXMT) for devices sold within China. The company is lobbying the US government to allow broader use of CXMT's products despite rising geopolitical tensions and US efforts to limit China's tech influence. CXMT, backed partly by the Chinese government, is expanding its market share and aims to become a major player in the global DRAM market. This move highlights the complex balance Apple faces between supply chain diversification and geopolitical risks.
Apple's stock reached an all-time high in 2026, rising over 16% year-to-date due to the AI boom boosting product sales. A $10,000 investment at the start of the year grew to $11,603 by late August, including dividends. The company reported strong Q3 ...
Apple posted its best June quarter ever with strong iPhone 17 sales and $109.42 billion revenue, but faces supply constraints and one-time tariff benefits. Microsoft reported $90.01 billion revenue with Azure growing 43% and a massive $678 billion co...
In the second quarter, family offices increased their stock allocations from 34% to 37%, driven by bullishness on AI and equities despite market bubble concerns. This shift was largely due to market gains, with the S&P 500 rising about 15%, rather th...
Nvidia is well positioned to benefit from the $3 trillion AI datacenter expansion without taking on the financial risks faced by major tech companies. Big Tech giants like Microsoft, Amazon, Alphabet, Oracle, and Meta have accumulated over $3 trillio...
Fidelity Contrafund (FCNTX), managed by Will Danoff, charges a 0.74% fee for retail investors, but an identical portfolio is available at a 0.45% fee through the K6 share class (FLCNX) in many 401(k) plans. The lower fee class offers the same holding...
